CBT and rehabilitation likely to improve long covid symptoms

FDA bi­o­log­ics cen­ter di­rec­tor Pe­ter Marks said the agency plans to en­cour­age spon­sors to use the ac­cel­er­at­ed ap­proval path­way, par­tic­u­lar­ly for rare dis­ease treat­ments, as

The shortage of crucial cancer drugs has eased a bit, but the vast majority of cancer centers are still “living paycheck to paycheck.” (STAT) Final

On the heels of con­t­a­m­i­na­tion con­cerns, the FDA on Thurs­day pub­lished draft guid­ance on qual­i­ty con­sid­er­a­tions for top­i­cal eye treat­ments, di­rect­ing man­u­fac­tur­ers to eval­u­ate vis­i­ble